Announcements
- EQS-PVR: BB BIOTECH AG: Disclosure of Shareholdings
- EQS-DD: BB BIOTECH AG: Dr. Thomas von Planta, buy
- EQS-Adhoc: BB Biotech AG publishes its interim report
- EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
- EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
- EQS-DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy
- EQS-Adhoc: BB Biotech AG publishes its 2023 annual report
- EQS-News: Investor interest returns – dividend yield remains high for 2024
More ▼
Key statistics
On Friday, BB Biotech AG (BBZX.N:GER) closed at 41.90, 13.24% above the 52 week low of 37.00 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.70 |
---|---|
High | 42.80 |
Low | 41.85 |
Bid | 41.80 |
Offer | 42.05 |
Previous close | 43.10 |
Average volume | 16.45k |
---|---|
Shares outstanding | 55.40m |
Free float | 54.42m |
P/E (TTM) | 7.59 |
Market cap | 2.36bn CHF |
EPS (TTM) | 5.62 CHF |
Annual div (ADY) | 2.05 EUR |
---|---|
Annual div yield (ADY) | 4.76% |
Div ex-date | Mar 25 2024 |
Div pay-date | Mar 27 2024 |
Data delayed at least 15 minutes, as of May 10 2024 16:35 BST.
More ▼